Ann: Quarterly Activity and Cashflow Report, page-35

You rightly pointed out that those numbers do not account for investors that participated in the more recent capital raises managed by Novus Capital.

I’m sure that AN and the FIJ board is aware who is behind this.

Undoubtedly there are concerns about the Leilo acquisition. It’s not a fait accompli. But there are obvious advantages to Leilo also. It’s not a one sided acquisition. The combined company would be the largest listed Kava company in the world, have better and cheaper access to raw materials, access to capital market funding, scalability, better access to markets etc etc.

If the deal falls through, it would be bad for both companies. And the deal falling through would likely mean that Leilo would soon have a formidable competitor that they otherwise wouldn’t have.

I think it will still happen. The terms may be amended slightly - but I reckon it will be finalised very soon.